Key facts
- This page summarizes Alexander L. Johnson's Form 4 filing for CareDx, Inc. (CDNA).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 22 Aug 2024, 17:15.
Alexander L. Johnson - 20 Aug 2024 Form 4 Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- President of Patient and Testing Services
- Issuer ticker
- CDNA
- Reported as of
- 20 Aug 2024
- Net transaction value
- -$578,594
- SEC form
- 4
- Accepted by SEC
- 22 Aug 2024, 17:15:39 UTC
- Prior SEC filing
- 21 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexander L. Johnson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alexander L. Johnson filed Form 4 for CareDx, Inc. (CDNA) on 22 Aug 2024.
Change
- Previous filing in this sequence was filed on 21 Aug 2024.
- Current net transaction value: -$578,594.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDNA
transaction
Common Stock
Options Exercise
- Transaction value
- $926,662
- Shares
- +39,466
- Change %
- +14%
- Price
- $23.48
- Shares after
- 324,449
- Date
- 20 Aug 2024
- Ownership
- Direct
CDNA
transaction
Common Stock
Sale
- Transaction value
- $1,309,087
- Shares
- -39,466
- Change %
- -12%
- Price
- $33.17
- Shares after
- 284,983
- Date
- 20 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
CDNA
transaction
Common Stock
Options Exercise
- Transaction value
- $506,158
- Shares
- +21,557
- Change %
- +7.6%
- Price
- $23.48
- Shares after
- 306,540
- Date
- 21 Aug 2024
- Ownership
- Direct
CDNA
transaction
Common Stock
Sale
- Transaction value
- $702,327
- Shares
- -21,557
- Change %
- -7%
- Price
- $32.58
- Shares after
- 284,983
- Date
- 21 Aug 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDNA
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -39,466
- Change %
- -36%
- Price
- $0.000000
- Shares after
- 71,126
- Date
- 20 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,466
- Exercise price
- $23.48
- Footnotes
- F3
CDNA
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -21,557
- Change %
- -30%
- Price
- $0.000000
- Shares after
- 49,569
- Date
- 21 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,557
- Exercise price
- $23.48
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.98, inclusive.
Footnote F3
1/4th of the shares subject to this option vested on June 16, 2023 and the remaining 3/4th of the shares subject to this option will vest monthly thereafter in 35 equal installments of 2,347 shares and one installment of 281 shares, until fully vested.
SEC remarks
President of Patient and Testing Services